Collegium Pharmaceutical sells prescription medicines for ADHD and pain in the United States. It last closed at $24.72 on Nov 20, down 1.94% on the day. The next earnings report for COLL is expected around Thu, Feb 25, 2027. For the quarter ended Sep 2026, COLL reported EPS of $0.60 on revenue of $216.3M, with revenue up 3.3% from a year ago. Over its last 8 reports the stock moved an average of 8.5% the session after earnings. Over the last 12 months COLL insiders bought $0 of stock on the open market and sold $4.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is COLL in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold COLL.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on COLLStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
COLL · as of the Nov 20 close · updated each morning
Bounce inside a longer downtrend
The stock is 1% above its 20 day and 6% above its 50 day average. It is 28% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 54). The nearest support is the 20 day average at $24.44, and the nearest resistance the Pivot at $24.93.
Short trendBullish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityNormal, 3.7%/day
Key levels
$50.7952 week high+105.5%
$31.61200 day average+27.9%
$27.03100 day average+9.3%
$26.39Swing high (Nov 5)+6.8%
$25.22Pivot R1+2.0%
$24.93Pivot+0.8%
$24.72Last close
$24.4420 day average−1.1%
$24.43Pivot S1−1.2%
$23.2550 day average−5.9%
$22.15Swing low (Oct 23)−10.4%
$21.4352 week low−13.3%
Indicators
RSI (14)
53.68
Middle of its range
Neutral
MACD
0.54
Above its signal line
Bullish
Stochastic
63.9
Middle of its range
Neutral
ADX (14)
30.3
Trending up
Williams %R
-56.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
47.1
Oversold below −100, overbought above 100
Neutral
Rate of change
+2.1%
Change over 10 sessions
Bullish
ATR (14)
$0.91
Typical daily range, 3.7% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityNormal, 10.4%/day
Key levels
$50.7952 week high+105.5%
$31.61200 day average+27.9%
$27.03100 day average+9.3%
$26.39Swing high (Nov 5)+6.8%
$25.22Pivot R1+2.0%
$24.93Pivot+0.8%
$24.72Last close
$24.4420 day average−1.1%
$24.43Pivot S1−1.2%
$23.2550 day average−5.9%
$22.15Swing low (Oct 23)−10.4%
$21.4352 week low−13.3%
Indicators
RSI (14)
38.65
Weak, oversold below 30
Neutral
MACD
-2.88
Above its signal line
Bullish
Stochastic
35.3
Middle of its range
Neutral
ADX (14)
25.4
Trending down
Williams %R
-60.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
-26.4
Oversold below −100, overbought above 100
Neutral
Rate of change
+8.7%
Change over 10 sessions
Bullish
ATR (14)
$2.56
Typical daily range, 10.4% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for COLL
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how COLL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow COLL usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for COLLHow many large options trades hit COLL, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in COLL in the last 90 days.
From SEC Form 4 filings by COLL's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether COLL is in one of them and how their past COLL trades turned out.
Collegium Pharmaceutical is a biopharmaceutical company based in Stoughton, Massachusetts. It sells prescription medicines in the United States for attention deficit hyperactivity disorder and for moderate to severe pain. Its products include Jornay PM for ADHD, Belbuca, Xtampza ER and the Nucynta products for pain, and Symproic for constipation caused by opioid use. Its customers are patients who receive these medicines through prescriptions written by doctors.